The 12th Invest in ME Conference, Part 1
OverTheHills presents the first article in a series of three about the recent 12th Invest In ME international Conference (IIMEC12) in London.
Discuss the article on the Forums.

Viralym-M, a T cell product, treats up to 5 different viral infections

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by Ema, Jul 18, 2018.

  1. Ema

    Ema Senior Member

    Messages:
    4,698
    Likes:
    6,848
    Midwest USA
     
    Limitless1, Moof, pattismith and 9 others like this.
  2. Hip

    Hip Senior Member

    Messages:
    11,048
    Likes:
    18,443
    Just emailed them asking if they might consider doing clinical trials with ME/CFS patients.
     
    Moof, Sancar, Sidny and 12 others like this.
  3. junkcrap50

    junkcrap50 Senior Member

    Messages:
    320
    Likes:
    469
    Thought I'd add this quote from their homepage:
    Theoretically, you could "educate" the T-cells to enteroviruses too.
     
    Moof, Ema, Sancar and 1 other person like this.
  4. Sidny

    Sidny

    Messages:
    83
    Likes:
    168
    Have there been any further developments with this? The latest lastest news on their site is over a year old now. This in theory and apparently in practice seems like a holy grail antiviral therapy.

    Wish this technology could go open source and we could all benefit from eradicating these potentially deadly viral infections without all the red tape involved.

    Please keep us updated @Hip on what the company says about trials for me/cfs patients and thank you for asking them.
     
    Moof likes this.
  5. Hip

    Hip Senior Member

    Messages:
    11,048
    Likes:
    18,443
    Will do. If they reply to my email that is.
     
    Moof and Sancar like this.

See more popular forum discussions.

Share This Page